Carregant...
The immunometabolite S-2-hydroxyglutarate regulates CD8(+) T-lymphocyte fate
R-2-hydroxyglutarate accumulates to millimolar levels in cancers with gain-of-function isocitrate dehydrogenase 1/2 mutations. These levels of R-2-hydroxyglutarate affect 2-oxoglutarate-dependent dioxygenases. Both R- and S-2-hydroxyglutarate, the other enantiomer of this metabolite, are detectible...
Guardat en:
| Publicat a: | Nature |
|---|---|
| Autors principals: | , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5149074/ https://ncbi.nlm.nih.gov/pubmed/27798602 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nature20165 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|